News from NORD

VHL Alliance Publishes Suggested VHL Surveillance Guidelines


 

The VHL Alliance has published suggested surveillance guidelines approved by the VHLA Clinical Advisory Council regarding testing for individuals at risk for von Hippel-Lindau disease (VHL) who do not yet have symptoms or those who are known to have VHL but do not yet symptoms in a particular area. The unaffected organs should still be screened. Read the screening guidelines. View a list of organs that can be impacted by VHL.

Recommended Reading

What Are New and Potential Therapies for Neuromuscular Disorders?
MDedge Neurology
Recognizing anti-NMDA receptor encephalitis psychosis on the psych ward
MDedge Neurology
Follow-Up of Infants With Zika Virus Identifies Several Neurologic Impairments
MDedge Neurology
NORD Urges Congress to Pass 21st Century Cures Act
MDedge Neurology
Nominate a Colleague for a NORD 2017 Rare Impact Award
MDedge Neurology
FDA Awards 21 Grants for Rare Disease Product Development
MDedge Neurology
Free Genetic Testing Program Is Launched for Patients With Inherited Retinal Diseases
MDedge Neurology
Undiagnosed Diseases Network Seeks Patients With Similar Symptoms
MDedge Neurology
MAPRx Publishes Its Annual Guide for Medicare Part D Open Enrollment
MDedge Neurology
Certification in Rare Neuroimmunologic Disorders
MDedge Neurology